Insulin Delivery Devices Market Size, Share & Trends Analysis and Forecast - 2025

The global insulin delivery devices market is projected to grow at a CAGR of 8.7% during 2019-2025. Various pivotal factors are boosting the market growth such as rising incidence and prevalence rate of diabetes, increasing awareness among the population towards diabetes and availability of a variety of insulin delivery devices in the market. Insulin is a necessary element required for the treatment of diabetes patients. Insulin enables a person’s body to use glucose from carbohydrates in the food consumed by the patient for future use.

Get Sample Copy of Insulin Delivery Devices Market at: https://www.omrglobal.com/request-sample/insulin-delivery-devices-market-size

Some of the key players operating in the market include Novo Nordisk A/S, Eli Lilly and Co., Sanofi SA, Becton, Dickinson, and Co., and Medtronic PLC. Merger & acquisition, product launch, investment in R&D,

Rising diabetes patients are considered to be a key driver in the growth of the global insulin delivery devices market. According to the International Diabetes Federation (IDF), around 425 million people had diabetes across the globe in 2017, and this number is further estimated to rise to 6 million by 2045. This significant increase in the diabetes population will increase the demand for insulin, which in turn, will spur the growth of the global insulin delivery devices industry in the near future.

Additionally, government support and their reimbursement policies in some countries such as the US are positively driving the market growth. The federal government offers financial support to diabetes patients by providing them various health insurance. Medicare, the Children's Health Insurance Program (CHIP), TRICARE, and veterans' health care programs are some programs that support patients. Moreover, some acts such as the Affordable Care Act (ACA) prevents insurers from denying coverage or charging higher premiums to people with preexisting conditions, such as diabetes are also fueling the market considerably. The features of insulin delivery devices including its accuracy, efficiency, and cost-effectiveness attract customers from different regions and thus drive market growth.

For More Information, get A full report of Insulin Delivery Devices Market is available at: https://www.omrglobal.com/industry-reports/insulin-delivery-devices-market-size

However, there is a lack of reimbursement policies in some emerging economies such as Bulgaria; the Czech Republic and others which do not give so much priority to diabetes. In addition to policies, the risk of infections associated with some devices such as insulin pens and syringes acts as a restraint for the market. The adoption of oral insulin as an alternative to these devices, which is negatively impacting the growth of the insulin delivery devices market. Besides, technological advancement and innovations to prevent diabetes and the significant rise in the amount of spending on diabetes are expected to create opportunities in the near future.

Market Segmentation

Global Insulin Delivery Devices Market by Type

• Insulin Syringes
• Insulin Pens
• Insulin Jet Injectors
• Insulin Pumps

Global Insulin Delivery Devices Market by End-User

• Hospitals & Clinics
• Homecare

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/insulin-delivery-devices-market-size

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.